Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513303 | 1.00 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL275280 | 0.80 | SMN1; SMN2 (0.52) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL6450453 | 0.79 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL225761 | 0.78 | — | — | |
| SCHEMBL10805452 | 0.77 | SMN1; SMN2 (0.50) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL26658220 | 0.77 | SMN1; SMN2 (0.50) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL6520334 | 0.77 | TSHR (0.42) | CA14CA12CA1CA2MAPT | |
| SCHEMBL28487412 | 0.77 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14KMT2ACA12ALDH1A1 | |
| SCHEMBL6520341 | 0.77 | TSHR (0.42) | CA14CA12CA1CA2MAPT | |
| SCHEMBL15709922 | 0.75 | ALDH1A1 (0.42) | KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | SMN1; SMN2 1768/4885CA14 3721/4885KMT2A 1067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.